A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution

Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838)
11/2002
11/14/2002	US20020169131 TGF-alpha polypeptides, functional fragments and methods of use therefor
11/14/2002	US20020169122 Chondrogenic potential of human bone marrow-derived CD105+ cells by BMP
11/14/2002	US20020169105 Use of active enamel substances as wound healing, anti-bacterial and/or anti-inflammatory agents
11/14/2002	US20020168767 Isolating human nervous system tissue from fetal tissue; obtain human fetal cells, culture, immunodeplete, isolate nervous system tissue
11/14/2002	US20020168764 Generation and recovering of preferential viral particles; obtain cells, infect with virus, extract virus from cells using detergent, recover virus
11/14/2002	US20020168763 Isolated homozygous stem cells, differentiated cells derived therefrom, and materials and methods for making and using same
11/14/2002	US20020168754 Nucleotide sequences coding polypeptides for use in the treatment of gastric, testicular, retinal, nervous system and immunological disorders
11/14/2002	US20020168420 Endothelial lining effects and treatment of vasospastic disorders
11/14/2002	US20020168416 Indian green mussel (Perna viridis) as a source of anti-HIV activity
11/14/2002	US20020168415 Biocompatible; culture product; anticancer agents
11/14/2002	US20020168388 Topical cosmetic composition
11/14/2002	US20020168382 Inducing immunology response
11/14/2002	US20020168366 Administering a binding agent capable of binding platelets binding platelets to the binding agent to form captured platelets, inducing activation of the captured platelets and forming a thrombus, which provides therapeutic benefit
11/14/2002	US20020168350 Methods for treating disorders of neuronal deficiency with bone marrow-derived cells
11/14/2002	US20020168349 A viral DNA construct encoding for a virus capable of replication in a human or animal tumor cell and causing death of such tumor cells
11/14/2002	US20020168348 Prolonging the acceptance of a graft by administering a short course of an immunosuppressant
11/14/2002	US20020168347 Monocyte derived cells, in a purified form, presenting antigenic epitopes on their membranes after interioriztion and processing of an antigen-antibody complex, such epitope corresponding to proteolytic degradation product of antigen
11/14/2002	US20020168344 Sensitization of chemotherapeutic agent resistant neoplastic cells with a virus
11/14/2002	CA2446788A1 Compositions and methods for the therapy and diagnosis of prostate cancer
11/14/2002	CA2446362A1 Submucosal xenografts
11/14/2002	CA2446204A1 Anti-virus agent
11/14/2002	CA2445982A1 Sperm-specific cation channel, and uses therefor
11/14/2002	CA2445713A1 A method for preparing lactic acid fermented solution of mushroom and lactic acid fermented solution of mushroom produced thereby
11/14/2002	CA2441417A1 Human secreted proteins
11/14/2002	CA2408968A1 Adsorbent for endocrine disruptors and foods and drinks containing the same
11/13/2002	EP1256354A1 Methods for treating cancer
11/13/2002	EP1256349A1 Cell activator
11/13/2002	EP1255849A2 Recombinant rhabdoviruses as live-viral vaccines for immunodeficiency viruses
11/13/2002	EP1255829A2 Inhibitor of hepatocyte growth factor activator for use in modulation of angiogenesis and cardiovascularization
11/13/2002	EP1255813A1 Multipotent neural stem cells from peripheral tissues and uses thereof
11/13/2002	EP1255746A1 Oxy- and amino-substituted tetrahydrofuryl derivatives with antimour activity
11/13/2002	EP1255559A2 Use of inhibitors of caspase-3 or caspase-activated desoxyribonuclease (cad) for treating cardiac disease
11/13/2002	EP1255456A1 Use of glutamate and/or a glutamate precursor for the preparation of a nutritional or pharmaceutical preparation for the treatment or prevention of hyperpermeability or undesired permeability of the intestinal wall
11/13/2002	EP1255452A2 A method for maintaining or improving the synthesis of mucins
11/13/2002	EP1255447A2 Biopolymer thickener
11/13/2002	EP1255439A1 Therapeutic platelets and methods
11/13/2002	EP0843557B1 Methods for detecting, identifying, isolating, and selectively labelling and targeting th1 lymphocytes by means of the lag-3 protein
11/13/2002	EP0806959B1 Method for preparing macrophages and kits therefor
11/13/2002	EP0774981B1 Injectable non-immunogenic cartilage and bone preparation
11/13/2002	CN1379821A Nucleic acid transporter containing polypeptide and recombinant virus vector
11/13/2002	CN1379820A Lentiviral vectors for preparation of immunotherapeutical compositions
11/13/2002	CN1379817A Composition and methods for increasing cholesterol efflux and raising HDL using ATP binding cassettte ttansporter protein ABC1
11/13/2002	CN1379814A Embryonic or stem-like cell lines produced by cross species nuclear transpcantation and methods for enhancing mebryonic development by genetic alteration of donor cells or by tissue culture conditions
11/13/2002	CN1379681A therapeutic angiogenic factors and methods for their use
11/13/2002	CN1379680A New class of bioactive glycoprotein
11/13/2002	CN1379676A Blood plasma replacement composition
11/13/2002	CN1378854A Medicine for treating cholelithiasis and its preparing process
11/13/2002	CN1378852A Detoxicating ointment for treating burn and scald and its preparing process
11/13/2002	CN1378849A Chinese medicine for treating femur head necrosis and its preparing process
11/13/2002	CN1378847A 鲨鱼软骨胶囊 Shark Cartilage Capsules
11/13/2002	CN1378846A Shark-liver oil softgel
11/13/2002	CN1378845A Ursine seal penis capsule
11/13/2002	CN1378844A Ursine seal tablet for making bone robust
11/13/2002	CN1378843A Ursine seal fat softgel
11/13/2002	CN1094152C 光合细菌的应用及利用它制得的产品 Application of photosynthetic bacteria and use it to obtain the product
11/13/2002	CN1094062C Chinese medicine for treating hepatitis B together with aweto-cephalosporin mycelium and its preparation
11/13/2002	CN1094061C Medicine for curing appendicities and its preparing method
11/13/2002	CN1094059C Medicinal drops for treating dental caries
11/13/2002	CN1094057C Liver ascites treating medicine
11/13/2002	CN1094056C Medicinal tablet with anti-senility function
11/13/2002	CN1094052C Anticancer goose blood preparation
11/12/2002	US6479545 Formulation for menopausal women
11/12/2002	US6479290 Chimeric adenoviral vectors
11/12/2002	US6479283 Stimulation, culture and preservation of pancreatic cells
11/12/2002	US6479064 Culturing different cell populations on a decellularized natural biostructure for organ reconstruction
11/12/2002	US6479054 Process for obtaining genistin-rich isoflavone composition
11/12/2002	US6479052 Spray delivery of cells
11/12/2002	US6479051 Oral administration of lactobacillus for the treatment and prevention of urogenital infection
11/12/2002	US6479050 Trace element-rich additive, method for preparing same, preparation in which the additive is included and use thereof
11/12/2002	US6478967 Removal of contaminants from biological products
11/12/2002	CA2176738C Method and composition for transfer of active tumor-specific immunization from an immunized allogeneic bone marrow donor
11/12/2002	CA2156486C Mucosal competitive exclusion flora
11/12/2002	CA2088289C Pharmaceutically active composition extracted from tanacetum parthenium, process for its extraction, and pharmaceutical composition containing same
11/12/2002	CA2086516C Methods for processing red blood cell products for long term storage free of microorganisms
11/12/2002	CA2085258C Method for growth promotion of animals and powder compositions containing killed microbial cells of bacteria belonging to genus clostridium
11/08/2002	WO2001082942A1 Compositions and methods for treatment of multiple myeloma
11/08/2002	CA2425954A1 Compositions and methods for treatment of multiple myeloma
11/07/2002	WO2002088351A1 Modified organs and cells for xenotransplantation
11/07/2002	WO2002088348A2 Lipid producing cells and uses thereof
11/07/2002	WO2002088337A1 Olfactory ensheathing glia produced by introducing telomerase
11/07/2002	WO2002088336A2 Genetically modified yt cell line and use thereof
11/07/2002	WO2002088335A1 Stem cells and method of separating the same
11/07/2002	WO2002088334A1 Chimeric immunoreceptor useful in treating human cancers
11/07/2002	WO2002088332A1 Small liver cell-rich colony, method of preparing the same, method of maturing the same into liver tissue and method of estimating drug function using the matured small liver cell-rich colony
11/07/2002	WO2002088331A1 Tridimensional biocompatible support structure for bioartificial organs and uses thereof
11/07/2002	WO2002088330A2 Neural progenitor cells
11/07/2002	WO2002088328A2 Method for generating highly active human dendritic cells from monocytes
11/07/2002	WO2002088317A2 Fusion molecules and methods for treatment of immune diseases
11/07/2002	WO2002088180A2 Use of alpha 1-antichymotrypsin for the manufacture of a composition for treatment, prevention or diagnosis of poorly healing diabetic or arterial wounds
11/07/2002	WO2002087626A1 Pharmaceutical compositions comprising dendritic cells for immunotherapy of autoimmune disease and treatment methods using the same
11/07/2002	WO2002087623A1 Microparticle protection of therapeutic agents
11/07/2002	WO2002087612A2 Use of stimulated peripheral blood mononuclear cells for treating cancerous diseases
11/07/2002	WO2002087603A1 Immunopotentiators
11/07/2002	WO2002087560A1 Carboxylic acid such as citric acid for desinfecting or enhacing the production of blood products such as plasma, cryoprecipitate or/and platelet
11/07/2002	WO2002087511A2 Modulators of elastase inhibitor secretion
11/07/2002	WO2002087336A1 Foot and mouth disease virus vaccine
11/07/2002	WO2002068614A3 Interferon regulatory factor-1/human estrogen receptor fusion protein and its use for treating carcinomas
11/07/2002	WO2002047697A3 Fractions of snake blood, their preparation and use as therapeutic agents
11/07/2002	WO2002028424A3 Kyberdrug as autovaccines with immune-regulating effects
11/07/2002	WO2002024930A3 Artificial ubiquitous chromatin opening elements (ucoe)

1 ... 938 939 940 941 942 943 944 945 946 947 948 949 950 951 952 953 954 955 956 957 958 ... 1259